Claim · model-written summary
Terminalia avicennioides, T. macroptera and T. laxiflora extracts inhibited 50% of DPPH at 0.04 to 0.6 mg/mL.
- Taxon
- Terminalia avicennioides , Terminalia macroptera, and Terminalia laxifloraTerminalia avicennioides
Terminalia macropteraTerminalia laxiflorae2 - Outcome
- inhibition of DPPHe2
- Value
- 50 %e2
- Qualifier
- concentrations ranging from 0.04 to 0.6 mg/mLe2
Not reportedMaterialGeneCompoundOrgan / stageInteractorInteractor roleSecond interactorSecond interactor roleTreatmentComparatorSettingDirection
Organisms pictured · Representative pictures of the matched species, not figures from the paper.
.jpg?width=500)
Verbatim
e2“Terminalia avicennioides , Terminalia macroptera, and Terminalia laxiflora extracts demonstrated 50 % inhibition of DPPH at concentrations ranging from 0.04 to 0.6 mg/mL”
Title
Jotham Yhi-pênê N'do; Dramane Paré; Loyapin Bondé; et al. Heliyon 2024. doi:10.1016/j.heliyon.2024.e40159
Other claims from this paper (5)
- Intervention effect Hydroethanolic, ethanolic and hexane bark extracts of Terminalia species inhibited the growth of bacteria and fungi.
- Observation Terminalia species had MICs ranging from 0.1 to 6.25 mg/mL against the tested bacteria and fungi.
- Observation Total phenolics and flavonoids were present in the three Terminalia species.
- Observation Isorhamnetin, quercetin and ferulic acid were identified by HPLC in ethanolic extracts of T. avicennioides.
- Recommendation The ethanolic extract of T. avicennioides can be used in phytomedicinal formulations.